LISLE, Ill., Dec. 11, 2017 /PRNewswire/ — Endotronix, Inc., a digital health medtech company providing innovative solutions for heart failure management, today announced that it has been named by FierceMedTech as one of 2017’s Fierce 15 MedTech companies, recognizing it as one of the most promising private medical technology companies in the industry. “We are honored […]
Rhythm
AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias
MOUNTAIN VIEW, Calif., Dec. 12, 2017 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (EKG) technology, today announced issuance of a U.S. patent which covers the use of data collected from wearable devices as a means of assisting diagnoses of heart arrhythmias, including those that may be asymptomatic. U.S. Patent […]
Imricor Awarded NIH Contract to Develop MR Compatible Catheter for MRI-Guided Cardiac Procedures
Minneapolis, MN – December 5, 2017 – Imricor Medical Systems announced that it has been awarded a contract for up to $2.4 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to develop an MR compatible injection catheter for MRI-guided procedures. This ten month […]
BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) — BioTelemetry(NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple(NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study. […]
CardioFocus® Completes Successful Controlled U.S. Commercial Launch of the HeartLight® System
MARLBOROUGH, Mass., Nov. 29, 2017 /PRNewswire/ — CardioFocus, Inc. today announced the successful completion of its controlled U.S. commercial launch of the HeartLight® Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF). Ten leading cardiac centers across the country have initiated HeartLight programs. The HeartLight System is a visually guided laser balloon technology for controlled […]
ZOLL and Myant Enter Strategic Research and Development Collaboration
CHELMSFORD, Mass. & TORONTO–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, and Myant, Inc., a high-tech advanced manufacturing company that is pioneering the application of technology and soft electronics into textiles, today announced that they have entered an exclusive strategic multi-year agreement to […]
Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers
DUBLIN – November 20, 2017 – Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology. Available in both single chamber and dual chamber models, the Azure XT MRI and Azure S MRI pacemakers offer improved longevity, estimated at 13.7 […]
LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million
LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]
Cardiac Insight Secures First Cardiology Customers for Its Wearable ECG Sensor, Cardea SOLO™
KIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Insight, a U.S. developer of wearable medical devices and diagnostic software, announced today that the company has secured its first cardiology customers for its wearable ECG sensor device, Cardea SOLO, in Texas and several other states. Early physician and patient experiences with Cardea SOLO are confirming the […]
EBR Systems, Inc. Raises $50 Million to Complete Global Heart Failure Trial
SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s first and only wireless cardiac pacing system for heart failure, has raised $50 million to conduct the global SOLVE-CRT study. The financing was led by Australian private equity firms M.H. Carnegie & Co. and Brandon Capital Partners and included participation by […]



